These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 35259978)

  • 1. Efficacy and tolerability of combination treatment of topiramate and greater occipital nerve block versus topiramate monotherapy for the preventive treatment of chronic migraine: A randomized controlled trial.
    Chowdhury D; Mundra A; Datta D; Duggal A; Krishnan A; Koul A
    Cephalalgia; 2022 Aug; 42(9):859-871. PubMed ID: 35259978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Greater occipital nerve blockade for the preventive treatment of chronic migraine: A randomized double-blind placebo-controlled study.
    Chowdhury D; Tomar A; Deorari V; Duggal A; Krishnan A; Koul A
    Cephalalgia; 2023 Feb; 43(2):3331024221143541. PubMed ID: 36739512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.
    Dodick DW; Freitag F; Banks J; Saper J; Xiang J; Rupnow M; Biondi D; Greenberg SJ; Hulihan J;
    Clin Ther; 2009 Mar; 31(3):542-59. PubMed ID: 19393844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
    Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
    Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
    Silberstein SD; Lipton RB; Dodick DW; Freitag FG; Ramadan N; Mathew N; Brandes JL; Bigal M; Saper J; Ascher S; Jordan DM; Greenberg SJ; Hulihan J;
    Headache; 2007 Feb; 47(2):170-80. PubMed ID: 17300356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occipital nerve block for the short-term preventive treatment of migraine: A randomized, double-blinded, placebo-controlled study.
    Dilli E; Halker R; Vargas B; Hentz J; Radam T; Rogers R; Dodick D
    Cephalalgia; 2015 Oct; 35(11):959-68. PubMed ID: 25505035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Letter to the editor regarding "Efficacy and tolerability of combination treatment of topiramate and greater occipital nerve block versus topiramate monotherapy for the preventive treatment of chronic migraine: A randomized controlled trial".
    Viganò A; Toscano M; Petolicchio B; Bianchi A; Cabrini DM; Di Piero V
    Cephalalgia; 2022 Nov; 42(13):1443-1444. PubMed ID: 35786012
    [No Abstract]   [Full Text] [Related]  

  • 8. Topiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measures.
    Silberstein S; Lipton R; Dodick D; Freitag F; Mathew N; Brandes J; Bigal M; Ascher S; Morein J; Wright P; Greenberg S; Hulihan J
    Headache; 2009 Sep; 49(8):1153-62. PubMed ID: 19719543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topiramate for migraine prevention: a randomized controlled trial.
    Brandes JL; Saper JR; Diamond M; Couch JR; Lewis DW; Schmitt J; Neto W; Schwabe S; Jacobs D;
    JAMA; 2004 Feb; 291(8):965-73. PubMed ID: 14982912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylaxis of migraine, transformed migraine, and cluster headache with topiramate.
    Mathew NT; Kailasam J; Meadors L
    Headache; 2002 Sep; 42(8):796-803. PubMed ID: 12390644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind comparison of onabotulinumtoxina (BOTOX) and topiramate (TOPAMAX) for the prophylactic treatment of chronic migraine: a pilot study.
    Mathew NT; Jaffri SF
    Headache; 2009; 49(10):1466-78. PubMed ID: 19912346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of tiapride and topiramate in the prophylactic treatment of chronic migraine: a randomised, double-blind, pilot study].
    Juica-Avello S; Riquelme-Vergara C; Condeza-Riquelme F; González-Burboa A; Fuentealba-Sandoval M; Klaassen-Pinto G; Pérez-Villalobos C; Vera-Calzaretta A; Contreras-Espinoza L; Werlinger-Estay E; Herrera-Hormazábal C
    Rev Neurol; 2022 May; 74(10):325-330. PubMed ID: 35548913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of simultaneous administration of occipital nerve block and cervical myofascial trigger point injection (MTrPI) on headache parameters in chronic migraine patients.
    Ercan M; Ertekin A
    Ir J Med Sci; 2024 Aug; 193(4):2001-2009. PubMed ID: 38451438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TOP-PRO study: A randomized double-blind controlled trial of topiramate versus propranolol for prevention of chronic migraine.
    Chowdhury D; Bansal L; Duggal A; Datta D; Mundra A; Krishnan A; Koul A; Gupta A
    Cephalalgia; 2022 Apr; 42(4-5):396-408. PubMed ID: 34579560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topiramate intervention to prevent transformation of episodic migraine: the topiramate INTREPID study.
    Lipton RB; Silberstein S; Dodick D; Cady R; Freitag F; Mathew N; Biondi DM; Ascher S; Olson WH; Hulihan J
    Cephalalgia; 2011 Jan; 31(1):18-30. PubMed ID: 20974598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial.
    Winner P; Pearlman EM; Linder SL; Jordan DM; Fisher AC; Hulihan J;
    Headache; 2005; 45(10):1304-12. PubMed ID: 16324162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventive effect of greater occipital nerve block on patients with episodic migraine: A randomized double-blind placebo-controlled clinical trial.
    Malekian N; Bastani PB; Oveisgharan S; Nabaei G; Abdi S
    Cephalalgia; 2022 May; 42(6):481-489. PubMed ID: 34786992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind, dose comparison study of topiramate for prophylaxis of basilar-type migraine in children: a pilot study.
    Lewis D; Paradiso E
    Headache; 2007; 47(10):1409-17. PubMed ID: 18052950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Greater occipital nerve block in chronic migraine.
    Saracco MG; Valfrè W; Cavallini M; Aguggia M
    Neurol Sci; 2010 Jun; 31 Suppl 1():S179-80. PubMed ID: 20464617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of galcanezumab in patients for whom previous migraine preventive medication from two to four categories had failed (CONQUER): a multicentre, randomised, double-blind, placebo-controlled, phase 3b trial.
    Mulleners WM; Kim BK; Láinez MJA; Lanteri-Minet M; Pozo-Rosich P; Wang S; Tockhorn-Heidenreich A; Aurora SK; Nichols RM; Yunes-Medina L; Detke HC
    Lancet Neurol; 2020 Oct; 19(10):814-825. PubMed ID: 32949542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.